简介:摘要本研究建立了高效液相色谱法测定当归消炎胶囊中阿魏酸的含量,以控制当归消炎胶囊的质量.样品经提取后,色谱柱为PhenomenexODS3柱(250×4.6nm,5μm),流动相为乙腈-0.085%磷酸溶液(17∶83);流速为1mL/min;检测波长为316nm;柱温为室温;进样量20μl下进行高效液相色谱法研究分析.本方法简单可行、稳定可控.关键词当归消炎胶囊;高效液相色谱;阿魏酸;含量测定中图分类号R284文献标识码ADOI10.1016/j.issn.2095-8578.2015.01.064
简介:摘要目的分析腺苷蛋氨酸联合熊去氧胆酸治疗妊娠期内胆汁淤积症的临床效果.方法选择70例妊娠期内胆汁淤积症患者作为研究对象,将随机分为对照组和观察组,每组35例.其中对照组患者单纯使用腺苷蛋氨酸进行治疗,观察组患者采用熊去氧胆酸联合腺苷蛋氨酸联合熊去氧胆酸进行治疗.比较两组患者治疗前后血清总胆酸(TBA)、谷草转氨酶(AST)、谷丙转氨酶(ALT)、总胆红素(TB)变化情况,瘙痒评分得分情况以及妊娠结局.结果治疗后,所有患者的TBA、TB、AST、ALT以及瘙痒评分与治疗前相比均显著降低(P<0.05);治疗后观察组患者的TBA、TB、AST、ALT以及瘙痒评分显著低于对照组患者(P<0.05);观察组患者发生羊水污染、早产、新生儿窒息、新生儿体重异常等情况发生率显著低于对照组患者(P<0.05).结论腺苷蛋氨酸联合熊去氧胆酸治疗妊娠期内胆汁淤积症的临床治疗效果显著,能够明显改善患者的妊娠结局,制的临床推广使用.关键词妊娠期;胆汁淤积症;熊去氧胆酸;腺苷蛋氨酸AbstractObjectivetoanalysisofadenosinemethioninecombinedwithursodeoxycholicacidinthetreatmentofpregnancytheclinicaleffectofintrahepaticcholestasis.Methodsselect70casesofpregnancyperiodcholestasispatientsastheresearchobject,wererandomlydividedintocontrolgroupandobservationgroup,35casesineachgroup.Patientsofthecontrolgroup,patientsonlyademetioninetreatment,observationgrouppatientsweretreatedwithursodeoxycholicacidcombinedwithTransmetilcombinedbeardeoxycholicacid.Werecomparedbetweenthetwogroupsbeforeandaftertreatmentinpatientswithserumtotalbileacid(TBA),aspartateaminotransferase(AST),alanineaminotransferase(ALT),totalbileredhormone(TB),pruritusscoretoAndpregnancyoutcome.ReGsultsaftertreatment,allpatientswithTBATB,AST,ALTandpruritusscorebeforetreatmentcomparedweresignificantlydecreased(P<0.05);aftertreatGment,theobservationgroupofpatientswithTBATB,AST,ALTandpruritusscorewassignificantlylowerthanthatofcontrolgroup(P<0.05);patientsintheobservationgroupoccurredamnioticfluidpollution,prematurebirth,neonatalasphyxia,neonatalweightabnormaloccurrenceratewassignificantlylowerthanthatofthecontrolgroup(P<0.05).ConclusionadenosinemethioninecombinedwithursodeoxycholicacidinthetreatmentofpregnancywithremarkableeffectkoefytwhoerdclinicaltreatmentofintrahepaticcholestasistosignificantlyimprovetheriskofThepregnancyoutcome,theclinicaluseofthesystem.pregnancy;intrahepaticcholestasis;ursodeoxycholicacid;s-ademetionine中图分类号R454文献标识码B文章编号1008-6315(2015)12-0152-02
简介:
简介:摘要目的研究分析二丁酰环磷腺苷钙联合生脉注射液治疗慢性心力衰竭的临床疗效.方法选取2013年3月~2014年4月期间来我院就诊的78例慢性心力衰竭患者,随机划分为实验组和对比组,每组患者39例,两组患者都采取常规治疗的方法,实验组在常规治疗的基础上采取二丁酰环磷腺苷钙联合生脉注射液治疗,观察分析两组患者治疗结束后的临床效果.结果实验组总有效率为95.2%,显著高与对比组的80.1%;实验组N-末端B型利钠肽前体下降水平明显高于对比组,实验组LVEDD、LVEF改善状况显著优于对比组,两组间差异比较具有统计学意义(P<0.05).结论二丁酰环磷腺苷钙联合生脉注射液治疗慢性心力衰竭有着较好的临床效果,能有效改善患者临床症状及生活状态,值得在临床医学中推广应用.关键词二丁酰环磷腺苷钙;生脉注射液;慢性心力衰竭CurativeeffectofCalciumDibutyryladenosineCyclophosphatecombinedwithShengMaiInjectioninthetreatmentofchronicheartfailureHouJunAbstractobjectiveTostudythecurativeeffectofcalciumDibutyryladenosineCyclophosphatecombinedwithShengMaiInjectioninthetreatmentofchronGicheartfailure.MethodsSelected78casesofpatientswithchronicheartfailureinourhospitalfromMar2011toApr2012,theyweredividedintoexperimentalgroupandcontrolgroupwith39caseseach.Theyallreceivedroutinetreatment,buttheexperimentalgroupwouldhaveDibutyryladenosineCyclophosphatecomGbinedwithShengMaiInjectionandthencomparedthecurativeeffectoftwogroups.ResultsTwogroupshaveachievedgoodclinicalresults,andthetotalefficienGcyofexperimentalgroupwas95.2%,whichissignificantlyhigher80.1%ofcontrolgroup.ConclusionCalciumDibutyryladenosineCyclophosphatecombinedwithShengKMeyaiwIonrjdecstionhasgoodcurativeeffectinthetreatmentofchronicheartfailure,whichcanimprovetheclinicalsymptomsandthelifecondition.CalciumDibutyryladenosineCyclophosphate;ShengMaiInjection;chronicheartfailure中图分类号R541.6文献标识码B文章编号1008-6315(2015)12-0910-02
简介:摘要目的探究熊去氧胆酸联合丁二磺酸腺苷蛋氨酸对子宫内膜癌患者治疗后的保肝作用.方法将100例研究对象分为实验组和对照组,对照组采用常规保肝方式,实验组在常规保肝方式基础上采用熊去氧胆酸联合丁二磺酸腺苷蛋氨酸的保肝方式,比较两组保肝作用.结果实验组与对照组的各项肝功能指标在治疗前后差异显著具有统计学意义(P<0.05).不良反应情况对比两组之间差异不显著(P>0.05)结论针对子宫内膜癌患者的保肝治疗采用熊去氧胆酸联合丁二磺酸腺苷蛋氨酸的方式其保肝效果明显强于常规保肝方式,值得临床推广使用.关键词熊去氧胆酸联合丁二磺酸腺苷蛋氨酸;子宫内膜癌患者;保肝作用AbstractObjectiveExplorethehepatoprotectiveeffectofursodeoxycholicacidcombinedwithtwoDacidadenosinemethionineforthetreatmentofpatientswithenGdometrialcancerafter.MethodThe100subjectsweredividedintoexperimentalgroupandcontrolgroup.Patientsincontrolgroupweretreatedwithconventionalwayofliver,theexperimentalgroupintheconventionalwayofliverbasedontheprotectivewayofursodeoxycholicacidcombinedwithsuccinicacidadenosinemethionine,comparedtwogroupsofhepatoprotectiveeffect.ResultsThedifferencebetweentheexperimentalgroupandthecontrolgroupwasstatisticallysignificant(P<0.05).ThedifferencebeGtweenthetwogroupswasnotsignificant(P>0.05).ConclusionForpatientswithendometrialcancerprotectivetreatmentwithursodeoxycholicacidcombinedwithDingademetKioenyinweoritdsshepatoprotectiveeffectwasstrongerintheconventionalwayofliver,worthyofclinicaluse.TwosulfonicacidofS-adenosylmethioninecombinedwithursodeoxycholicacid;Endometrialcarcinoma;hepatoprotectiveeffect中图分类号R969.3文献标识码B文章编号1008-6315(2015)10-0146-01
简介:目的评价骨质疏松骨折术后应用唑来膦酸的临床疗效。方法选取2012年1月至2014年2月本组收治的骨质疏松骨折患者30例,其中女24例,男6例;年龄53~80岁,平均(67.6±8.1)岁。所有患者均予手术治疗,术后给予唑来膦酸注射液5mg静脉滴注,其中术后5~7d应用5例,术后1个月25例。术后12、24、36个月复查并记录骨密度变化,同时观察骨折愈合情况,记录治疗期间的症状和不良发应。结果本组患者治疗1年后骨密度均有所提高,且差异有统计学意义(P<0.05),连续应用3年骨密度持续提高,差异有统计学意义(P<0.05)。首次给予唑来膦酸治疗后,均出现不同程度的发热、乏力、头痛、关节痛、恶心等反应,再次应用不良反应明显减少(P<0.05)。无骨折不愈合、骨不连、术后内固定松动、断裂,螺钉退出等并发症发生。无再骨折发生。结论骨质疏松骨折术后应用唑来膦酸可以有效降低再骨折率、提高骨密度,且并不影响骨折愈合。